A LYVE-1/CRSBP-1 Mutation in Inherited Primary Lymphedema.

Area of Science:

• Genetics
• Vascular Biology
• Molecular Medicine

Background:

• Primary lymphedema exhibits genetic and clinical heterogeneity, with mutations in ~20 genes identified.
• The LYVE-1 (cell-surface retention sequence binding protein-1, CRSBP-1) gene encodes a key hyaluronan receptor and lymphatic vessel marker.
• The precise role of LYVE-1 in lymphatic system development and disease pathogenesis is not fully understood.

Purpose of the Study:

• To investigate the role of LYVE-1 mutations in inherited primary lymphedema.
• To characterize the clinical and lymphatic imaging findings associated with LYVE-1 mutations.

Main Methods:

• Genetic analysis of an inherited lymphedema family across three generations.
• Identification of a missense mutation (c.18C>G, p.S6R) in the LYVE-1 gene.
• Lymphatic imaging to assess lymphatic vessel structure and function.

Main Results:

• A novel missense mutation (p.S6R) in the N-terminal extension domain of LYVE-1 was identified in affected family members.
• Lymphatic imaging demonstrated partial, weak, and delayed enhancement of tortuous lymph collectors in the lower limbs.
• The identified LYVE-1 mutation was associated with both structural and functional lymphatic defects.

Conclusions:

• Germline mutations in LYVE-1/CRSBP-1 are implicated in primary lymphedema.
• LYVE-1 mutations contribute to structural and functional abnormalities of lymphatic vessels.
• This study highlights LYVE-1 as a significant gene in lymphatic system development and disease.